LAMEDITECH Co., Ltd. (KOSDAQ:462510)
3,260.00
-85.00 (-2.54%)
At close: Jun 5, 2026
LAMEDITECH Revenue
LAMEDITECH had revenue of 815.41M KRW in the quarter ending March 31, 2026, a decrease of -57.65%. This brings the company's revenue in the last twelve months to 6.08B, down -19.21% year-over-year. In the year 2025, LAMEDITECH had annual revenue of 7.19B with 9.28% growth.
Revenue (ttm)
6.08B
Revenue Growth
-19.21%
P/S Ratio
4.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.19B | 610.60M | 9.28% |
| Dec 31, 2024 | 6.58B | 3.66B | 125.37% |
| Dec 31, 2023 | 2.92B | 862.48M | 41.95% |
| Dec 31, 2022 | 2.06B | 1.03B | 99.85% |
| Dec 31, 2021 | 1.03B | 824.53M | 403.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| Ray Co., Ltd. | 112.53B |
| Bio Plus | 94.42B |
| LabGenomics | 84.19B |
| T&R Biofab | 29.73B |
| HASS Corp. | 16.58B |
| Sugentech | 9.87B |